AP NEWS

Atopic Dermatitis Market - 2018-2028 - with Focus on 21 Major Markets - ResearchAndMarkets.com

July 12, 2018

DUBLIN--(BUSINESS WIRE)--Jul 12, 2018--The “Epiomic Epidemiology Series: Atopic Dermatitis Forecast In 21 Major Markets 2018-2028” report has been added to ResearchAndMarkets.com’s offering.

This report provides the current prevalent population for Atopic Dermatitis across 21 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Russia, Turkey, South Africa, Japan, China, South Korea, Singapore, India, Australia, Brazil, Mexico, Argentina) split by gender and 5-year age cohort. Along with the current prevalence, the report provides an overview of severity, location and IgE levels of Atopic Dermatitis, to name a few. The report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team, several of the main symptoms and co-morbidities of Atopic Dermatitis have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Atopic Dermatitis include:

Asthma Rhinitis Allergies (Food- or Inhalant-related) Rashes Eczemic lesions

Reasons to buy

Able to quantify patient populations in global Atopic Dermatitis market to target the development of future products, pricing strategies and launch plans. Gain further insight into the prevalence of the subdivided types of Atopic Dermatitis and identify patient segments with high potential. Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries. Provide a level of understanding on the impact from specific co-morbid conditions on Atopic Dermatitis prevalent population. Identify sub-populations within Atopic Dermatitis which require treatment. Gain an understanding of the specific markets that have the largest number of Atopic Dermatitis patients.

Key Topics Covered:

Introduction Cause of the Disease Risk Factors & Prevention Diagnosis of the Disease Variation by Geography/Ethnicity Disease Prognosis & Clinical Course Key Comorbid Conditions/Features Associated with the Disease Methodology for Quantification of Patient Numbers Top-Line Prevalence for Atopic Dermatitis Features of Atopic Dermatitis Patients Abbreviations used in the Report Other Services & Solutions Reports & Publications Online Epidemiology Databases Online Pharmaceutical Pricing Database References Appendix

For more information about this report visit https://www.researchandmarkets.com/research/tqpsdp/atopic_dermatitis?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180712005553/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Dermatological Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 07/12/2018 10:39 AM/DISC: 07/12/2018 10:39 AM

http://www.businesswire.com/news/home/20180712005553/en

AP RADIO
Update hourly